Phenergan 25mg/ml Inj, 1ml

Manufacturer WEST-WARD Active Ingredient Promethazine Injection(proe METH a zeen) Pronunciation proe METH a zeen
WARNING: For all patients taking this drug:Severe tissue damage has happened with this drug. Sometimes, this has led to surgery. Tell your doctor or nurse right away if you have any burning, numbness, coldness, color changes (like skin turning red, purple, or black), pain, skin breakdown, pus, or swelling where the shot was given.This drug is injected into the muscle. Some doses may be given into a vein. This drug must not be injected into the fatty tissue under the skin or into an artery.Children:Do not give this drug to a child younger than 2 years of age. It may cause very bad and sometimes deadly breathing problems. Use with care in children 2 years of age and older. Talk with the doctor.Before your child takes this drug, tell the doctor if your child is taking any drugs that can cause breathing problems. There are many drugs that can do this. Ask the doctor or pharmacist if you are not sure. @ COMMON USES: It is used to ease allergy signs.It is used to help motion sickness.It is used to prevent upset stomach and throwing up from surgery.It is used during surgery.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihistamine, Antiemetic, Sedative
đŸ§Ŧ
Pharmacologic Class
Phenothiazine derivative, H1-receptor antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1951
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Promethazine injection is a medicine given by shot to help with nausea and vomiting, allergic reactions, or to make you feel sleepy before a procedure. It works by blocking certain natural substances in your body.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Adhere to the instructions carefully. This medication is administered via injection into a muscle or, in some cases, into a vein.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.

Missing a Dose

If you miss a dose, contact your doctor to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedating medications while taking this drug, as it can increase drowsiness.
  • Avoid driving or operating heavy machinery until you know how this medication affects you.
  • Stay hydrated, especially if experiencing nausea/vomiting.
  • Report any unusual symptoms or pain at the injection site immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: For Nausea/Vomiting: 12.5 to 25 mg IM/IV every 4-6 hours as needed. For Allergic Reactions: 25 mg IM/IV, may repeat in 2 hours if needed. For Sedation: 25 to 50 mg IM/IV at bedtime or preoperatively.
Dose Range: 12.5 - 50 mg

Condition-Specific Dosing:

nausea_vomiting: 12.5-25 mg IM/IV every 4-6 hours PRN
allergic_reactions: 25 mg IM/IV, may repeat in 2 hours if needed
sedation: 25-50 mg IM/IV at bedtime or preoperatively
đŸ‘ļ

Pediatric Dosing

Neonatal: Contraindicated in children younger than 2 years of age due to risk of fatal respiratory depression.
Infant: Contraindicated in children younger than 2 years of age due to risk of fatal respiratory depression.
Child: For Nausea/Vomiting: 0.5 mg/kg IM/IV every 4-6 hours as needed; max 25 mg/dose. For Sedation: 0.5-1 mg/kg IM/IV at bedtime or preoperatively; max 50 mg/dose. (Not for <2 years old)
Adolescent: Same as adult dosing, generally 12.5-25 mg IM/IV for nausea/vomiting or allergic reactions, 25-50 mg for sedation.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Use with caution; consider lower doses or extended intervals.
Severe: Use with caution; consider lower doses or extended intervals due to potential for accumulation of metabolites.
Dialysis: Not significantly dialyzable. Use with caution; monitor for adverse effects.

Hepatic Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Use with caution; consider lower doses or extended intervals due to impaired metabolism.
Severe: Use with caution; consider lower doses or extended intervals due to impaired metabolism and increased risk of adverse effects.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Promethazine is a phenothiazine derivative that acts as a potent, competitive H1-receptor antagonist. It also possesses significant anticholinergic, antidopaminergic, and weak alpha-adrenergic blocking activity. Its antiemetic effects are thought to be due to its central anticholinergic action and direct depression of the chemoreceptor trigger zone (CTZ). Its sedative effects are due to its antihistaminic and anticholinergic properties.
📊

Pharmacokinetics

Absorption:

Bioavailability: Not available (IM/IV administration bypasses first-pass metabolism)
Tmax: IM: 20-60 minutes; IV: Immediate
FoodEffect: Not applicable for injection

Distribution:

Vd: 171 L (high)
ProteinBinding: Approximately 93% (to plasma proteins)
CnssPenetration: Yes (readily crosses blood-brain barrier)

Elimination:

HalfLife: 10-14 hours (range 7-19 hours)
Clearance: Not available
ExcretionRoute: Renal (primarily as inactive metabolites), Fecal (minor)
Unchanged: <1% (urine)
âąī¸

Pharmacodynamics

OnsetOfAction: IM: 20 minutes; IV: 3-5 minutes
PeakEffect: IM: 30-60 minutes; IV: 5-10 minutes
DurationOfAction: 4-6 hours (can be up to 12 hours for sedative effects)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

RESPIRATORY DEPRESSION: Promethazine HCl Injection is contraindicated for use in pediatric patients less than 2 years of age because of the potential for fatal respiratory depression. Postmarketing cases of respiratory depression, including fatalities, have been reported with use of promethazine in pediatric patients less than 2 years of age. Caution should be exercised when administering promethazine HCl Injection to pediatric patients 2 years of age and older. It is recommended that the lowest effective dose of promethazine HCl Injection be used in pediatric patients 2 years of age and older and concomitant administration of other drugs with respiratory depressant effects be avoided. SEVERE CHEMICAL IRRITATION AND DAMAGE INCLUDING GANGRENE: Promethazine HCl Injection can cause severe chemical irritation and damage to tissues, regardless of the route of administration. This damage can result from perivascular extravasation, inadvertent intra-arterial injection, and intraneuronal or perineuronal infiltration. The most severe cases have resulted in amputation. The preferred route of administration is deep intramuscular (IM) injection. Subcutaneous injection is contraindicated. Intra-arterial injection is contraindicated. Intravenous (IV) injection is not the preferred route of administration. If IV administration is used, it should be administered via a large-bore, patent vein, preferably through a central venous line, at a concentration not exceeding 25 mg/mL and at a rate not exceeding 25 mg/minute. The maximum recommended dose is 25 mg. The IV push method of administration is not recommended. Dilution of the injection to a concentration of 25 mg/mL is strongly recommended.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Abnormal heartbeat (fast or slow)
Trouble controlling body movements, including:
+ Twitching
+ Changes in balance
+ Difficulty swallowing or speaking
Shakiness, difficulty moving around, or stiffness
Confusion
Feeling nervous and excitable
Hallucinations (seeing or hearing things that are not there)
Mood changes
Ringing in the ears
Seizures
Unexplained bruising or bleeding
Yellowing of the skin or eyes
Changes in eyesight
Neuroleptic malignant syndrome (NMS), a potentially life-threatening condition, which may cause:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast or irregular heartbeat
+ Excessive sweating
Severe breathing problems, including:
+ Slow or shallow breathing
+ Difficulty breathing
Low white blood cell counts, which may increase the risk of infection, including:
+ Fever
+ Chills
+ Sore throat

Other Possible Side Effects

Most people experience few or no side effects while taking this medication. However, if you notice any of the following side effects, contact your doctor or seek medical attention if they bother you or do not go away:

Dizziness
Drowsiness
Fatigue
Weakness
Blurred vision
Dry mouth
Upset stomach or vomiting
Trouble sleeping
Stuffy nose

Reporting Side Effects

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Difficulty breathing, very slow or shallow breathing
  • Severe drowsiness or inability to wake up
  • Confusion, hallucinations
  • Uncontrolled muscle movements (tremors, twitching)
  • Fever, stiff muscles, sweating, fast or uneven heartbeats (signs of NMS)
  • Severe pain, burning, swelling, redness, or blistering at the injection site
  • Yellowing of skin or eyes (jaundice)
  • Unusual bleeding or bruising
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
If you have respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), or sleep apnea, which involves breathing difficulties during sleep.
If you have liver problems or a history of Reye's syndrome, a rare but serious condition.

Please note that this list is not exhaustive, and it is crucial to discuss all your health concerns with your doctor.

To ensure safe treatment, it is vital to provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
Your complete medical history, including all health problems

Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe to do so in conjunction with your other medications and health conditions.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Before operating a vehicle or engaging in activities that require alertness and clear vision, wait until you understand how this medication affects you.

This drug may interfere with the accuracy of certain pregnancy tests. If you are pregnant or suspect you may be pregnant, consult your doctor.

If you have diabetes, it is crucial to closely monitor your blood sugar levels while taking this medication.

Prior to consuming alcohol, using marijuana or other cannabis products, or taking prescription or over-the-counter medications that may impair your reactions, discuss the potential risks with your doctor.

You may be more susceptible to sunburn while taking this medication. To minimize this risk, avoid exposure to direct sunlight, sunlamps, and tanning beds. Use protective measures such as sunscreen, clothing, and eyewear that provide adequate sun protection.

This medication may increase the risk of seizures, particularly in individuals with a history of seizure disorders. Consult your doctor to determine if you are at a higher risk of experiencing seizures while taking this medication.

If you have a sulfite allergy, inform your doctor, as some formulations of this medication may contain sulfites.

If you are 65 years or older, exercise caution when taking this medication, as you may be more prone to experiencing side effects.

If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Respiratory depression (slow, shallow breathing)
  • Hypotension (low blood pressure)
  • Tachycardia (fast heart rate)
  • Anticholinergic effects (dilated pupils, dry mouth, flushed skin, urinary retention, bowel obstruction)
  • Seizures
  • Extrapyramidal symptoms
  • Cardiovascular collapse

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive, including maintaining airway, assisting ventilation, managing hypotension, and controlling seizures. Naloxone may be considered if opioid co-ingestion is suspected. Physostigmine may be used for severe anticholinergic symptoms but with caution.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • MAO inhibitors (concurrent use or within 14 days of MAOI discontinuation) - increased anticholinergic effects and CNS depression
  • Other CNS depressants (e.g., opioids, barbiturates, benzodiazepines, alcohol) in children <2 years old
🔴

Major Interactions

  • CNS depressants (e.g., opioids, barbiturates, benzodiazepines, general anesthetics, tricyclic antidepressants, alcohol) - additive CNS depression, respiratory depression, profound sedation
  • Anticholinergic drugs (e.g., atropine, scopolamine, tricyclic antidepressants) - additive anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation)
  • QT-prolonging drugs (e.g., antiarrhythmics, certain antipsychotics, macrolide antibiotics) - theoretical risk of additive QT prolongation
  • Dopamine agonists (e.g., bromocriptine, cabergoline) - promethazine's antidopaminergic effects may antagonize their action
  • Epinephrine - promethazine may reverse the vasopressor effect of epinephrine, leading to hypotension
🟡

Moderate Interactions

  • Antihypertensives - additive hypotensive effects
  • Cholinesterase inhibitors - antagonism of effects
  • Drugs metabolized by CYP2D6 (e.g., fluoxetine, paroxetine, quinidine) - potential for altered metabolism of promethazine or co-administered drug
  • Photosensitizing agents - additive photosensitivity
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history (allergies, current medications, pre-existing conditions like asthma, glaucoma, prostatic hypertrophy)

Rationale: To identify contraindications, potential drug interactions, and risk factors for adverse effects.

Timing: Prior to administration

Baseline vital signs (BP, HR, RR, temperature)

Rationale: To establish baseline for comparison and identify any pre-existing abnormalities.

Timing: Prior to administration

Assessment of respiratory status (especially in pediatric patients)

Rationale: To identify risk of respiratory depression, a serious adverse effect.

Timing: Prior to administration

📊

Routine Monitoring

Vital signs (BP, HR, RR)

Frequency: Every 15-30 minutes initially, then as clinically indicated

Target: Within patient's normal range, no significant hypotension or respiratory depression

Action Threshold: Significant drop in BP, bradycardia, respiratory rate <10-12 breaths/min (adult), or signs of respiratory distress

Level of consciousness/Sedation score

Frequency: Every 15-30 minutes initially, then as clinically indicated

Target: Desired level of sedation without excessive somnolence or unresponsiveness

Action Threshold: Excessive sedation, unarousable, paradoxical excitation

Injection site for IV administration

Frequency: Continuously during infusion, then regularly post-infusion

Target: No signs of pain, redness, swelling, or extravasation

Action Threshold: Any signs of pain, burning, swelling, redness, or blistering at the injection site (indicates extravasation/tissue injury)

đŸ‘ī¸

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing, cyanosis)
  • Excessive sedation/drowsiness
  • Dizziness, lightheadedness
  • Dry mouth, blurred vision, urinary retention, constipation (anticholinergic effects)
  • Hypotension
  • Extrapyramidal symptoms (dystonia, akathisia, parkinsonism) - rare but possible
  • Neuroleptic Malignant Syndrome (NMS) - very rare but serious (fever, muscle rigidity, altered mental status, autonomic instability)
  • Injection site pain, burning, swelling, redness, blistering, tissue necrosis (especially with IV administration)

Special Patient Groups

🤰

Pregnancy

Promethazine is Pregnancy Category C. Use only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. May cause respiratory depression in neonates if given close to delivery.

Trimester-Specific Risks:

First Trimester: Limited data, theoretical risk of teratogenicity based on animal studies at high doses.
Second Trimester: Generally considered safer than first trimester, but still Category C.
Third Trimester: Risk of respiratory depression, hyperreflexia, and hypotonia in neonates if administered within 2 weeks of delivery. Avoid use during labor and delivery.
🤱

Lactation

Promethazine is excreted into breast milk. The American Academy of Pediatrics considers it to be of 'concern' due to potential for sedation and respiratory depression in the infant. Use with caution, monitor infant for drowsiness, poor feeding, and respiratory issues. L3 (Moderately Safe).

Infant Risk: Sedation, irritability, poor feeding, respiratory depression (especially in young infants or with high doses).
đŸ‘ļ

Pediatric Use

Contraindicated in children younger than 2 years of age due to the risk of fatal respiratory depression. Use with extreme caution in children 2 years and older; use the lowest effective dose and avoid concomitant use with other respiratory depressants. Risk of extrapyramidal symptoms and paradoxical excitation (restlessness, agitation) is higher in pediatric patients.

👴

Geriatric Use

Use with caution in elderly patients due to increased susceptibility to anticholinergic effects (e.g., confusion, urinary retention, constipation, dry mouth, blurred vision), sedation, and orthostatic hypotension. Start with lower doses and titrate slowly. Avoid in patients with dementia-related psychosis.

Clinical Information

💎

Clinical Pearls

  • **Black Box Warning:** Absolutely contraindicated in children <2 years due to fatal respiratory depression. Also carries a severe tissue injury warning for IV administration.
  • **Preferred Route:** Deep intramuscular (IM) injection is the preferred route due to the risk of severe tissue damage (including gangrene requiring amputation) with IV administration.
  • **IV Administration Precautions:** If IV administration is necessary, dilute to 25 mg/mL, administer via a large-bore, patent vein (preferably central line), at a rate not exceeding 25 mg/minute. Avoid IV push. Monitor injection site meticulously.
  • **Extravasation Management:** If extravasation occurs, stop injection immediately, aspirate residual drug, infiltrate with hyaluronidase, apply warm compresses, and elevate the extremity. Consult plastic surgery if severe.
  • **Anticholinergic Effects:** Be aware of significant anticholinergic side effects (dry mouth, blurred vision, urinary retention, constipation), especially in elderly patients or those on other anticholinergic medications.
  • **Sedation:** Promethazine causes significant sedation. Advise patients to avoid driving or operating machinery.
  • **Photosensitivity:** Patients should be advised to use sun protection as promethazine can cause photosensitivity.
  • **Drug Interactions:** Potentiates CNS depressants (alcohol, opioids, benzodiazepines). Avoid concomitant use or reduce doses of other CNS depressants.
🔄

Alternative Therapies

  • For Nausea/Vomiting: Ondansetron (Zofran), Metoclopramide (Reglan), Prochlorperazine (Compazine), Dimenhydrinate (Dramamine)
  • For Allergic Reactions: Diphenhydramine (Benadryl), Hydroxyzine (Vistaril, Atarax)
  • For Sedation: Diphenhydramine, Hydroxyzine, Benzodiazepines (e.g., Midazolam, Lorazepam)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 1ml vial (25mg/ml)
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed otherwise, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the correct disposal method, consult your pharmacist for guidance. Many communities offer drug take-back programs, which your pharmacist can help you locate. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred, as this will aid in prompt and effective treatment.